Bismuth-based quadruple therapy modified with moxifloxacin for Helicobacter pylori eradication.
CONCLUSIONS: Moxifloxacin in modified bismuth-based quadruple therapy was found to be effective and safe with good drug compliance; therefore it may be an acceptable alternative to other second-line eradication protocols.
PMID: 27973462 [PubMed - as supplied by publisher]
Source: Minerva Gastroenterologica e Dietologica - Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research
More News: Avelox | Gastroenterology | Helicobacter Pylori | Metronidazole | Moxifloxacin | Nutrition | Pantoprazole | Protonix | Study